Table 2 Cost-effectiveness of prophylactic LPI versus that of observation (base-case and scenarios with different ages at entry and exit from the cohort).
Observation period | Strategy | Cost (JPY) | Incremental cost (JPY) | QALY | Incremental QALY | ICER (JPY/QALY) |
|---|---|---|---|---|---|---|
40–59 years of age (20-year horizon, base-case) | LPI | 449,050 | 55,572 | 16.67 | 0.02 | 2,287,662 |
Observation | 393,478 | Â | 16.65 | Â | Â | |
40–54 years of age (15-year horizon) | LPI | 368,602 | 60,784 | 13.10 | 0.02 | 3,958,450 |
Observation | 307,818 | Â | 13.09 | Â | Â | |
40–49 years of age (10-year horizon) | LPI | 280,195 | 66,526 | 9.16 | 0.01 | 7,610,359 |
Observation | 213,669 | Â | 9.15 | Â | Â | |
50–69 years of age (20-year horizon) | LPI | 449,037 | 55,615 | 16.67 | 0.02 | 2,294,626 |
Observation | 393,421 | Â | 16.65 | Â | Â | |
50–64 years of age (15-year horizon) | LPI | 368,596 | 60,803 | 13.10 | 0.02 | 3,966,008 |
Observation | 307,794 | Â | 13.09 | Â | Â | |
50–59 years of age (10-year horizon) | LPI | 280,194 | 66,531 | 9.16 | 0.01 | 7,617,443 |
Observation | 213,663 | Â | 9.15 | Â | Â | |
40–99 years of age | LPI | 880,510 | 23,196 | 35.40 | 0.19 | 124,675 |
(60-year horizon) | Observation | 857,314 | Â | 35.21 | Â | Â |